This application sought to permit the addition of citicoline as a nutritive substance for addition to formulated caffeinated beverages. It was withdrawn.
The regulation of infant formula products has recently been reviewed and gazettal of the new Standards is pending, following the Food Ministers’ Meeting on 25 July 2024. The new regulation is subject to a transition period of 5 years (inclusive of stock-in-trade). During the 5 year period, infant formula products may be sold if they comply with either the Code as in force (as if the variation had not taken effect) or the Code as amended by the draft variations.
This application seeks approval for the sale and use of food derived from corn line MON94804, genetically modified to have reduced overall plant height.
Stakeholders are invited to participate in aninteractive online session with the P1055 subject matter experts on 2 September 2024 from 11am-12pm (AEST) | 1-2pm (NZT). This session will provide a comprehensive overview of the proposal and include a live Q&A where you can ask questions and share your feedback. Register now
To permit Alpha-amylase (protein engineered) from a genetically modified strain of Bacillus licheniformis to be used as a processing aid in carbohydrate processing to produce glucose syrups and other starch hydrolysates in potable alcohol production.
To permit endo-1,4-beta-xylanase from a genetically modified strain of Bacillus lichenformis to be used as a processing aid in the production of distilled alcohol and starch and gluten fractions.
This application seeks approval for the sale and use of food derived from corn line DP910521, genetically modified for herbicide-tolerance and protection from insect pests.
This application seeks to amend the Australia New Zealand Food Standards Code to permit a new genetically modified source organism Corynebacterium glutamicum for the production of 2′-Fucosyllactose (2′-FL) for use in infant formula products.
